12/19
06:58 pm
vor
Form 4 Vor Biopharma Inc. For: Dec 18 Filed by: Kolchinsky Peter
High
Report
Form 4 Vor Biopharma Inc. For: Dec 18 Filed by: Kolchinsky Peter
12/19
06:17 pm
vor
Form 4 Vor Biopharma Inc. For: Dec 18 Filed by: Joustra Wouter
High
Report
Form 4 Vor Biopharma Inc. For: Dec 18 Filed by: Joustra Wouter
12/19
06:14 pm
vor
Form 4 Vor Biopharma Inc. For: Dec 18 Filed by: Levin Andrew David
Medium
Report
Form 4 Vor Biopharma Inc. For: Dec 18 Filed by: Levin Andrew David
12/19
06:07 pm
vor
Form 3 Vor Biopharma Inc. For: Dec 18 Filed by: Joustra Wouter
Medium
Report
Form 3 Vor Biopharma Inc. For: Dec 18 Filed by: Joustra Wouter
12/19
06:05 pm
vor
Form 3 Vor Biopharma Inc. For: Dec 18 Filed by: Levin Andrew David
Medium
Report
Form 3 Vor Biopharma Inc. For: Dec 18 Filed by: Levin Andrew David
12/19
04:40 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
Medium
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
12/18
06:31 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Medium
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
12/18
04:01 pm
vor
Form 8-K Vor Biopharma Inc. For: Dec 15
Medium
Report
Form 8-K Vor Biopharma Inc. For: Dec 15
12/17
04:00 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
High
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: GREAT POINT PARTNERS LLC
12/9
08:00 am
vor
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Mahatme Sandesh
Low
Report
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Mahatme Sandesh
12/9
08:00 am
vor
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Zuraw Qing Che
Low
Report
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Zuraw Qing Che
12/9
08:00 am
vor
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Kress Jean-Paul
Low
Report
Form 4 Vor Biopharma Inc. For: Dec 05 Filed by: Kress Jean-Paul
12/9
07:59 am
vor
Form 8-K Vor Biopharma Inc. For: Dec 05
Low
Report
Form 8-K Vor Biopharma Inc. For: Dec 05
12/1
04:11 pm
vor
Form 424B3 Vor Biopharma Inc.
Low
Report
Form 424B3 Vor Biopharma Inc.
11/18
04:30 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
High
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Paradigm Biocapital Advisors LP
11/14
06:13 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
11/12
07:03 am
vor
Form 8-K Vor Biopharma Inc. For: Nov 10
Low
Report
Form 8-K Vor Biopharma Inc. For: Nov 10
11/12
06:08 am
vor
Form 424B5 Vor Biopharma Inc.
Neutral
Report
Form 424B5 Vor Biopharma Inc.
11/10
04:26 pm
vor
Form 424B5 Vor Biopharma Inc.
High
Report
Form 424B5 Vor Biopharma Inc.
11/10
04:24 pm
vor
Form S-3/A Vor Biopharma Inc.
High
Report
Form S-3/A Vor Biopharma Inc.
11/7
11:14 am
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: FMR LLC
11/5
04:15 pm
vor
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
Medium
Report
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: Qiming Venture Partners VIII-HC, L.P.
11/3
08:02 am
vor
Form 8-K Vor Biopharma Inc. For: Nov 02
Medium
Report
Form 8-K Vor Biopharma Inc. For: Nov 02
10/30
06:42 pm
vor
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13D/A Vor Biopharma Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
10/30
06:41 pm
vor
Form 4 Vor Biopharma Inc. For: Oct 28 Filed by: Kolchinsky Peter
Low
Report
Form 4 Vor Biopharma Inc. For: Oct 28 Filed by: Kolchinsky Peter